close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Blue

Recent news which mentions Blue

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Why Bluebird Bio Stock Is Sinking Today
Tickers BLUE
Tags BLUE Recent Press Releases Market News
From Motley Fool
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Niu Technologies Shares Plunge
Tickers AZRE BBBY BCEL BLUE
Tags Small Cap NIU Market News
From Benzinga
Expert Ratings For bluebird bio
Tickers BLUE
Tags BLUE BZI/AAR Analyst Ratings
From Benzinga
Mid-Day Market Update: Nasdaq Drops 250 Points; Bed Bath & Beyond Shares Surge
Tickers BBBY BCEL BLUE CEI
Tags Benzinga TXMD Earnings
From Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Tickers ADTH AMR ATXI BBBY
Tags BBBY TUSK USEG
From Benzinga
Why Bluebird Bio Shares Are Tumbling Today
Tickers BLUE
Tags Penny Stocks BLUE gene therapy
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
Tickers AAL AU AUGX AZUL
Tags CHRS BMO Analyst Ratings
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tickers ATXI BBBY BCEL BLUE
Tags BCEL STAB ATXI
From InvestorPlace
A Peek Into The Markets: US Stock Futures Tumble; Crude Oil Jumps Over 7%
Tickers BLUE CIEN IEA NFLX
Tags Eurozone Markets Global
From Benzinga
5 Stocks To Watch For March 7, 2022
Tickers BLUE CIEN IEA SLGN
Tags Stocks to Watch Earnings Benzinga
From Benzinga
2 Dirt Cheap Biotechs to Buy If You're a Contrarian
Tickers BLUE KOD
Tags KOD BLUE Recent Press Releases
From Motley Fool
2 Money-Burning Biotech Stocks to Avoid
Tickers BLUE INO MRNA PFE
Tags MRNA INO Market News
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
Tickers AFRM AGNC AHI ALGS
Tags GTYH MOHO SHOP
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers ACHL ACVA AGEN AGI
Tags SQ DLB EHTH
From Benzinga
2 Biotech Stocks That Could Make You Richer
Tickers BLUE EXEL TSVT
Tags EXEL Market News Recent Press Releases
From Motley Fool
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
Tickers BLUE
Tags Health Care Market News Small Cap
From Benzinga
Why Bluebird Bio Stock Is Sinking This Week
Tickers BLUE JPM
Tags BLUE JPM Recent Press Releases
From Motley Fool
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
Tickers BLUE
Tags Trading Ideas Briefs General
From Benzinga
Where bluebird bio Stands With Analysts
Tickers BLUE
Tags Analyst Ratings Market News Benzinga
From Benzinga
Better Buy: CRISPR vs. Intellia
Tickers BLUE CRSP NTLA REGN
Tags VRTX BLUE NTLA
From Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers BFRI BLUE CFMS CGTX
Tags BFRI Movers Market News
From Benzinga
Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump
Tickers BLUE BRG CANF CCL
Tags SOPA News COCO
From Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Tickers ARBK ARGX ARQQ ASAN
Tags CTK SEV LCTX
From Benzinga
Why Bluebird Bio Stock Is Plunging Today
Tickers BLUE
Tags Market News Recent Press Releases BLUE
From Motley Fool
Why Are Bluebird Bio Shares Trading Lower Today?
Tickers BLUE
Tags Small Cap Health Care Movers
From Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
Tickers BLUE
Tags Briefs BLUE gene therapy
From Benzinga
Could This Soaring Biotech Stock Make You Rich?
Tickers BLUE KRYS NVS
Tags KRYS BLUE NVS
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers ARNA ATXI BFRI BLUE
Tags BLUE Pre/Market Outlook ARNA
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tickers APVO ARNA ATXI AVCT
Tags TXMD ATXI PTPI
From InvestorPlace
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags Trading Ideas Briefs News
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today